RPS6KA1 and breast carcinoma: In particular, treatment of cells with SL0101 or RNAi against RSK1 or -2 inhibits the proliferation of human prostate and breast cancer cells, suggesting that these two isoforms positively regulate cancer cell proliferation [5,15,23].